[Biotech&Pharma] MacroGenics Announces Date of Fourth Quarter and Full Year 2019 Financial Results Conference Call

Browse By

Rockville, MD, Feb. 13, 2020 (GLOBE NEWSWIRE) —

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter and full year 2019 after the market closes on Tuesday, February 25, 2020. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Tuesday, February …

Full story available on Benzinga.com

Source Benzinga

Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. The author is not paid to share this information. Cannabis Investment Group is not paid to share this information and has no business relationship other than shareholder with any company whose stock is mentioned in this article.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.